Martin David Solomon

MD | Neurology


  1600 W College St, Ste 470, Grapevine
     Texas, 76051-3584
  817-481-8100    817-421-6112 Maps & Directions
Martin David Solomon is a Grapevine, Texas based neurologist who is specialized in Neurology. His current practice location is 1600 W College St, Ste 470, Grapevine. Patients can reach him at 817-481-8100 or can fax him at 817-421-6112. Martin David Solomon is MD in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1962408583.
Martin David Solomon specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Martin David Solomon speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Martin David Solomon
Specialization: Neurology
Gender:Male
Credentials: MD
Practice Address:1600 W College St, Ste 470, Grapevine,
Texas, 76051-3584
Phone:817-481-8100
Fax:817-421-6112
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1962408583
NPI Enumeration Date: 28 Jun, 2005
NPI Last Update On: 07 Oct, 2008

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Martin David Solomon
1600 W College St, Ste 470
Grapevine, Texas
Zip: 76051-3584
Phone Number: 817-481-8100
Fax Number: 817-421-6112
Patients can reach Martin David Solomon at 1600 W College St, Ste 470, Grapevine, Texas or can call to book an appointment on 817-481-8100.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.